Merck Manual

Please confirm that you are a health care professional

Loading

Hemoglobin E Disease

By

Evan M. Braunstein

, MD, PhD, Johns Hopkins School of Medicine

Last full review/revision Mar 2019| Content last modified Mar 2019
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

Homozygous hemoglobin E (Hb E) disease is a hemoglobinopathy that causes a mild hemolytic anemia, usually without splenomegaly.

Hemoglobin (Hb) E is the 3rd most prevalent hemoglobin worldwide (after Hb A and Hb S). It occurs primarily in Southeast Asian (> 15% incidence of homozygous disease) populations, although rarely in people of Chinese descent. Heterozygotes (Hb AE) are asymptomatic. Patients heterozygous for Hb E and beta-thalassemia have a hemolytic disease more severe than hemoglobin S-beta-thalassemia or homozygous Hb E disease and usually have splenomegaly.

In heterozygotes (Hb AE), a microcytosis is present without anemia, and target cells can be seen on peripheral blood smear. In homozygotes, a mild microcytic anemia with prominent target cells exists.

Diagnosis of hemoglobin E disorders is by hemoglobin electrophoresis.

Most patients do not require treatment. However, patients with severe disease may benefit from chronic transfusions or splenectomy.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Overview of Disseminated Intravascular Coagulation...
Video
Overview of Disseminated Intravascular Coagulation...
Overview of Acute Leukemia
Video
Overview of Acute Leukemia

SOCIAL MEDIA

TOP